The chart of Cronos Group Inc. (CRON) shows a double top with $11.13 target or 9.00 % above today’s $10.21 share price.

The 8 months chart pattern indicates low risk for the $1.82 billion company. It was reported on Dec, 23 by Finviz.com. If the $11.13 price target is reached, the company will be worth $163.53M more.

Double tops are rare but powerful chart patterns.

The stock decreased 8.27% or $0.92 during the last trading session, reaching $10.21. About 6.91 million shares traded. Cronos Group Inc. (NASDAQ:CRON) has risen 277.71% since December 23, 2017 and is uptrending. It has outperformed by 277.71% the S&P500.

Cannabis producers in Southwestern Ontario – one of the nation’s emerging marijuana belts – are going on an expansion spree, a move an industry official says will help reduce the nation’s cannabis shortage.

The combination of high demand for pot products and growing pains in the nascent cannabis industry has led to empty shelves at online stores and bricks-and-mortar retailers across the country since recreational marijuana became legal in Canada on Oct. 17.

Meanwhile, the country’s legion of licensed growers, including several in the London region, are working around the clock to expand their operations to meet the growing demand for their products.

"I've never seen this before."

Manitoba Premier Brian Pallister, sitting in his legislature office for a year-end interview, is looking at a 15-ml container of cannabis spray. It's one of the ways through which recreational cannabis can be consumed since legalization in October.

It is discreet, quick, smokeless and — perhaps surprisingly under Manitoba law — legal to consume in most public places.

"My lunch could be really good," Pallister jokes before handing it back to the reporter who brought it to him.

The premier has said on more than one occasion he's more of a beer man.

Pallister's Progressive Conservative government is not alone in having to adjust to the complex realities of legalized recreational cannabis.

Marijuana stocks have been on a wild ride in 2018, and the pullback in the sector in the past two months has investors wondering which cannabis stocks might be the best buys heading into 2019.

Let’s take a look at HEXO (TSX:HEXO) and Canopy Growth (TSX:WEED)(NYSE:CGC) to see if one deserves to be in your portfolio right now.

Bruce Linton was in an ebullient mood on Thursday after Health Canada announced proposed rules that would allow Canadians to buy a wide range of cannabis products, including edibles and drinks.

Canopy is now building a 197,000-square-foot bottling plant next to the former chocolate factory that houses its Tweed marijuana grow-op.

Canopy has partnered with huge U.S. beer, wine and spirits company Constellation Brands to develop cannabis drinks. The draft regulations give a boost to those plans.

After the M&A wave died down in 2018, many analysts thought the so-called "Green Rush" was over, but we think they were wrong. With a combination of newcomers and veterans vying for market share, it's safe to say the competition is getting intense. And with competition comes innovation. Included in today's commentary are: Auxly Cannabis Group (OTC:CBWTF) (TSX.V:XLY), merald Health Therapeutics (OTC:EMHTF) (TSX.V:EMH), Curaleaf Holdings (OTC:CURLF) (CSE:CURA), OrganiGram Holdings (OTC:OGRMF) (TSX.V: OGI), CannTrust Holdings Inc. (OTC:CNTTF) (TSX:TRST). 

Imagine producing a product at $0.05 and selling it at $16 – or a 31,900% gross profit.

What you are imagining is one of the most efficient cannabis operations in the world today.

Wayland Group (WAYL.CN; OTC:MRRCF) can produce cannabis at $0.05 a gram in South American and sells cannabis for up to $16 in some European markets.

How do they do it?

With a simple, but powerful business strategy:

They focus on the lowest cost production methods.

Produce product in countries with weaker currencies.

Sell into the highest-paying markets that have strong currencies.

Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE:APHA) announced that the Company has completed its second shipment of approximately 80 L (equivalent to approximately 20 kg of dried bud) of medical cannabis to its Australian-based partner Althea Company Pty Ltd.("Althea").

Ottawa looks to limit THC concentration in cannabis edibles

Health Canada has released draft regulations for cannabis edibles and extracts, which include strict limits on dosage and ingredients.

For edibles, Health Canada is proposing plain child-resistant packaging, restricting the ingredients that can be used and limiting the edible to 10 milligrams of THC per package, which is largely considered the typical amount for a single dose. Additionally, regular food and edible cannabis products must not be produced in the same facility.